Basis: Four-quarter operating cash flow / FMP quote market capitalization × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The operating cash flow yield is N/A as of 2026-10-06T14:41:00.943Z.
Calculation as of: 2026-10-06T14:41:00.943Z.
Quote observation: 2026-10-06T14:40:21.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 2e8745362276acfcd64f5b9abcba69827836693d7b304a16c872192b0535814a
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
OPERATING CASH FLOW YIELD
N/A
Bicara Therapeutics Inc. Common Stock
Market Cap
$1.09B
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.09B
Operating Cash Flow Yield
2.50%
TTM Avg
2.27%
3Y Avg
2.68%
5Y Avg
2.53%
Market Cap
$1.11B
Operating Cash Flow Yield
16.66%
TTM Avg
15.61%
3Y Avg
12.04%
5Y Avg
9.55%
Market Cap
$1.11B
Operating Cash Flow Yield
0.56%
TTM Avg
1.29%
3Y Avg
0.78%
5Y Avg
1.14%
Market Cap
$1.05B
Operating Cash Flow Yield
24.76%
TTM Avg
24.50%
3Y Avg
20.47%
5Y Avg
14.92%
Market Cap
$1.13B
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.13B
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.04B
Operating Cash Flow Yield
4.09%
TTM Avg
6.70%
3Y Avg
7.23%
5Y Avg
7.23%
| NAME | MARKET CAP | OPERATING CASH FLOW YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Bicara Therapeutics Inc. Common Stock (BCAX) | $1.09B | N/A | N/A | N/A | N/A |
| IRadimed Corporation (IRMD)vs › | $1.09B | 2.50% | 2.27% | 2.68% | 2.53% |
| Amphastar Pharmaceuticals, Inc. (AMPH)vs › | $1.11B | 16.66% | 15.61% | 12.04% | 9.55% |
| Harrow Health, Inc. (HROW)vs › | $1.11B | 0.56% | 1.29% | 0.78% | 1.14% |
| Kardigan, Inc. (KARD)vs › | $1.15B | N/A | N/A | N/A | N/A |
| Teladoc Health, Inc. (TDOC)vs › | $1.05B | 24.76% | 24.50% | 20.47% | 14.92% |
| Damora Therapeutics, Inc. (DMRA)vs › | $1.13B | N/A | N/A | N/A | N/A |
| Avalyn Pharma Inc. Common Stock (AVLN)vs › | $1.13B | N/A | N/A | N/A | N/A |
| Castle Biosciences, Inc. (CSTL)vs › | $1.04B | 4.09% | 6.70% | 7.23% | 7.23% |
| GoodRx Holdings, Inc. (GDRX)vs › | $1.16B | 17.45% | 18.66% | 11.11% | 8.71% |
OCF Yield = TTM Operating Cash Flow / Market Cap
Operating cash flow yield is the inverse of P/OCF, expressing trailing operating cash flow as a percentage of price. It sits between earnings yield (before non-cash accrual effects) and FCF yield (before capital expenditure).
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
